Study finds “epigenomic” alterations evolve as lung tumors become more aggressive and metastasize.

Certain cancer therapeutics concentrate within cells — a finding that could change the way scientists think about drug design.

A new platform that precisely quantifies antigens presented on cell surfaces may help researchers and clinicians improve the effectiveness of cancer immunotherapies.

Engineers design nanoparticles that stimulate the immune system, helping it to attack tumors.

Pathologists who examined the computationally stained images could not tell them apart from traditionally stained slides.

Hadley Sikes designs simple-to-use diagnostic devices that could benefit patients around the world.

Study shows that a simple urine test can reveal the presence of lung cancer in mice.

An unusual synergy between cancer researchers, clinical centers, and industry leads to promising clinical trials for a new combination therapy for prostate cancer.

Using specialized liver cells, a new test can quickly detect potentially cancer-causing DNA damage.

Team of researchers including MIT Professor Angela Koehler obtains $5.8 million grant to study fusion-positive alveolar rhabdomyosarcoma.